We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+9.77%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.54B
AUM Growth
-$135M
(-8.1%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-13.95%
Top 10 Holdings %
Top 10 Hldgs %
25.05%
Holding
1,512
New
379
Increased
290
Reduced
289
Closed
425
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$10.9M |
| 2 |
ARNC
Arconic Corporation
ARNC
|
+$7.33M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$7.14M |
| 4 |
NetEase
NTES
|
+$7.01M |
| 5 |
Micron Technology
MU
|
+$6.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$65.4M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$62.2M |
| 3 |
Li Auto
LI
|
+$29.4M |
| 4 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
+$15.1M |
| 5 |
Alibaba
BABA
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.1% |
| 2 | Consumer Discretionary | 11.71% |
| 3 | Healthcare | 9.05% |
| 4 | Industrials | 8.79% |
| 5 | Financials | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPI
701
Farmland Partners
FPI
$432M
| $265K | 0.02% |
21,720
+6,365
| +41% | +$71.3K |
|
|
EMCG
702
DELISTED
Embrace Change Acquisition Corp
EMCG
| $265K | 0.02% |
25,000
| – | – |
|
|
FSR
703
DELISTED
Fisker Inc.
FSR
| $264K | 0.02% |
46,836
-5,614
| -11% | -$32.4K |
|
|
PLYA
704
DELISTED
Playa Hotels & Resorts
PLYA
| $262K | 0.02% |
+32,200
| New | +$292K |
|
705
Vanda Pharmaceuticals
VNDA
$302M
| $262K | 0.02% |
39,760
+11,726
| +42% | +$75.2K |
|
706
Delta Air Lines
DAL
$60.1B
| $261K | 0.02% |
5,496
-7,556
| -58% | -$279K |
|
707
FirstCash
FCFS
$8.78B
| $261K | 0.02% |
+2,797
| New | +$273K |
|
|
APLS
708
DELISTED
Apellis Pharmaceuticals
APLS
| $261K | 0.02% |
+2,861
| New | +$247K |
|
709
NewMarket
NEU
$8.18B
| $261K | 0.02% |
+648
| New | +$253K |
|
710
Gain Therapeutics
GANX
$77.6M
| $260K | 0.02% |
58,100
| – | – |
|
711
CALL
Carvana
CVNA
$77.9B
| $259K | 0.02% |
+50,000
| New | +$139K |
|
|
JHG
712
DELISTED
Janus Henderson
JHG
| $259K | 0.02% |
+9,508
| New | +$254K |
|
|
PACW
713
DELISTED
PacWest Bancorp
PACW
| $258K | 0.02% |
31,681
+13,403
| +73% | +$108K |
|
714
Invesco CurrencyShares Japanese Yen Trust
FXY
$431M
| $258K | 0.02% |
+4,000
| New | +$271K |
|
|
RCM
715
DELISTED
R1 RCM Inc. Common Stock
RCM
| $258K | 0.02% |
+13,960
| New | +$227K |
|
|
HCVI
716
DELISTED
Hennessy Capital Investment Corp. VI Class A Common Stock
HCVI
| $257K | 0.02% |
+25,000
| New | +$255K |
|
717
Bunge Global
BG
$20.8B
| $256K | 0.02% |
2,714
-276
| -9% | -$25.6K |
|
718
New Oriental
EDU
$8.98B
| $256K | 0.02% |
6,476
-191,334
| -97% | -$7.65M |
|
719
PUT
FS KKR Capital
FSK
$3.44B
| $255K | 0.02% |
13,300
+1,600
| +14% | +$30.3K |
|
|
VTYX
720
DELISTED
Ventyx Biosciences
VTYX
| $254K | 0.02% |
+7,746
| New | +$267K |
|
721
Caterpillar
CAT
$387B
| $254K | 0.02% |
1,031
-24,961
| -96% | -$5.57M |
|
722
Arcturus Therapeutics
ARCT
$211M
| $253K | 0.02% |
8,826
-3,768
| -30% | -$103K |
|
723
Okta
OKTA
$25.8B
| $253K | 0.02% |
+3,647
| New | +$277K |
|
724
ePlus
PLUS
$2.34B
| $253K | 0.02% |
4,492
-548
| -11% | -$27K |
|
725
Addus HomeCare
ADUS
$2.23B
| $252K | 0.02% |
+2,720
| New | +$259K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Prelude Capital Management held 1,512 positions worth $1.54B, down 8.1% from $1.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Prelude Capital Management withdrew a net $214M in Q2 2023, closing 425 positions and reducing 289 holdings. Its most notable exit was Li Auto, an estimated $29.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Prelude Capital Management opened a new position in Arconic Corporation worth $7.86M.
- Prelude Capital Management's largest Q2 2023 buy was Arconic Corporation: 265,725 shares worth $7.86M.
- Prelude Capital Management added most to IVERIC bio, Inc. Common Stock in Q2 2023, an estimated $10.9M increase.
- Prelude Capital Management's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $65.4M.
- Prelude Capital Management fully exited Li Auto in Q2 2023, selling an estimated $29.4M.
- Prelude Capital Management's ten largest holdings make up 25% of its $1.54B portfolio in Q2 2023.
- Prelude Capital Management opened 379 new positions and closed 425 in Q2 2023.
- Prelude Capital Management's portfolio value fell 8.1% quarter-over-quarter to $1.54B.
Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.